ÂÜÀòÂÒÂ×

Nicolas Mourier is a seasoned pharmaceutical executive currently serving as Vice President of Pharmaceutical Development at Parabilis Medicines since October 2024, providing technical and operational leadership for drug development activities. Previously, Nicolas held senior roles in Chemistry Manufacturing and Control at Enzyvant, where oversight included the clinical development of products for pulmonary arterial hypertension and bronchiolitis obliterans syndrome. Additional experience includes positions at Anchiano Therapeutics and CSL Vifor, focusing on manufacturing and regulatory processes for various clinical products. With a strong foundation in organic and medicinal chemistry, evidenced by a PhD from Aix-Marseille University and master's and bachelor's degrees from the University of Montpellier, Nicolas has extensive experience in overseeing drug development and regulatory submissions across multiple organizations since 2003.